Tata Institute comes up with a ₹100 drug to prevent cancer recurrence; doctors to start human trials soon

[Hasan]

Tata Institute comes up with a ₹100 drug to prevent cancer recurrence; doctors to start human trials soon Researchers at the Tata Institute in Mumbai say they've developed a tablet aimed at preventing cancer recurrence. After 10 years of research, they believe that the drug will help prevent cancer from recurring in patients for a second time